Menu
ncarol.com
  • Home
  • Education
  • Health
  • Technology
  • Books
  • Entertainment
  • Real Estate
  • Music
  • Financial
ncarol.com

New Study Reveals Alarming Cardiac Risks Associated with Electroshock Treatment
ncarol.com/10274175

Trending...
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
Study Reveals Cardiac Risks Associated with ECT
The mental health industry watchdog, CCHR, says informed consent is breached every time patients are not warned of the brain damage, long-term memory loss, and cardiac risks, including death, associated with electroshock, per the study.

LOS ANGELES - ncarol.com -- A new study has determined that as many as 1 in 15 people who receive electroshock treatment face life-threatening heart problems, which can lead to death. John Read, Ph.D., a Professor of Psychology at the University College of London critiqued studies of electroconvulsive therapy (ECT) and cited a 2019 review that he says misrepresented data and falsely asserted that ECT is safe. In reality, cardiac events are the leading cause of death for those subjected to shock treatment.[1] The Citizens Commission on Human Rights International, a mental health industry watchdog, says this critical information must be transparently communicated to patients recommended for ECT, including the risks of permanent brain damage and memory loss. According to Dr. Read's study, "the ethical principle of informed consent is being routinely breached by ECT psychiatrists."

Jan Eastgate, President of CCHR International, says that for decades there has been a cover-up of the seriousness of the effects of ECT, which sends up to 460 volts of electricity through the brain, causing a grand mal seizure. "Electroshock has no place in mental health treatment and should be banned," she said, adding, "Given without a patient's consent is internationally recognized as constituting torture."

According to U.S. expert, Ken Castleman, a biomedical engineer, "ECT stimulates the sympathetic nervous system, which controls many aspects of cardiovascular function. The powerful electrical discharge causes a spike in blood pressure. The intense stress that the ECT-induced seizure places on the heart increases the risk of adverse cardiovascular events, especially in patients who have pre-existing cardiac conditions."

More on ncarol.com
  • The New World of Freight Brokering with AI
  • Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
  • World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
  • Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
  • Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties

Dr. Read reports, "The obligation to ensure informed consent is a core ethical principle of all health and mental health professionals." Yet, "Various official reports, most psychiatric textbooks, and many patient information leaflets have claimed, for decades, that the risk of death from ECT is so rare as to be inconsequential," including an American Psychiatric Association (APA) ECT Task Force Report on ECT. "It should be noted that six of the eight task force members were directors of ECT services." The group included three members who were financially involved with companies manufacturing ECT machines, Dr. Read wrote.

Citing the 2023 joint guidance by the World Health Organization/United Nations, Dr. Read continued: "People being offered ECT should be made aware of all its risks and potential short- and long-term harmful effects, such as memory loss and brain damage. ECT is not recommended for children, and this should be prohibited through legislation."

The study further discusses the death rate:
  • Of 8,148 ECT recipients in Texas, seven died within 2 days of their last ECT. Even excluding the two that the researchers believed were "unlikely to have been related to ECT," this is a "rate of 1 per 1,630 people. If one includes the additional eight that died, from 'cardiac events' in the following 12 days, the rate is 1 per 627."
  • A 2019 review of 43 ECT studies with mortality data, including more than 75,000 patients, calculated, "All-cause mortality was 0.42 deaths per 1,000 patients." This is 1 per 2,380 people, more than four times greater than the official position of the APA of 1 per 10,000.
  • A 2023 Swedish register-based study was comprehensive in finding that of 20,225 ECT patients, 123 (0.61%) died of "medical causes" within 30 days of their last ECT—one death per 164 people. At one per 413 patients, the 49 cardiac-related deaths represented the most common medical cause of post-ECT death (40%). This was surpassed only by the 93 suicides (1 per 217).  In total, 15 of the 23 patients who died within 24 hours of ECT were cardiovascular deaths.
As Dr. Read points out, in 2001, the APA acknowledged that "evidence has shown that ECT can result in persistent or permanent memory loss." In 2018, an ECT device manufacturer included "permanent brain damage" in its list of risks, yet this information was not being forwarded to patients.

More on ncarol.com
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • FOCUS Hires Carrier-Side Operations Leader to Build the Next Generation of Insurance Service Delivery
  • Adams Security Group LLC Launches New Website to Expand Professional Security Services Across Florida
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge

In the U.S., adolescents and even children five years old and younger have been electroshocked. Dr. Read found "rates of memory deficits in more than two-thirds of child and adolescent ECT patients" that were passed off as "acceptable" and misrepresented as a "high level of safety." Dr. Read wrote to the journal stating: "The use of sufficient electricity, once, on a developing brain, in order to cause a seizure in that young brain, is a very serious matter. To do so five or six times in a few weeks is almost bound to cause brain damage in a significant number of recipients. The average age of these youngsters was just 15.5 years. Most (62 %) were girls. When even the psychiatrists themselves acknowledge that 69 % have impaired memories as a result, this does not indicate a treatment with a 'high' degree of safety."

The main cardiac events Dr. Read found are myocardial infarction (heart attack), life-threatening arrhythmia (irregular heartbeat), acute pulmonary edema (fluid on the lungs), pulmonary embolism (blood clots), acute heart failure, and cardiac arrest.

In light of these grave risks, CCHR welcomes the recent news that electroshock is nearly on the brink of disappearing due to public awareness campaigns, including CCHR's documentary, Electroshock: Therapy or Torture. "It's an incredible story that goes back decades," says Harold Sackeim, a psychologist and major proponent of ECT, who is worried that exposure of ECT could be "successful at killing an industry."

Ms. Eastgate responds, "It is far better that the multi-billion-dollar electroshock industry be killed off rather than its patients. Their safety must be the priority. The current study and many others reflect the ongoing concerns that ECT should be banned."

About CCHR: Established in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz, CCHR has secured state bans of ECT use on minors. It also had Deep Sleep Treatment (DST), which includes ECT, banned in Australia, which last year the WHO said should be prohibited worldwide.

Source:

[1] Read, J. 2024. Major adverse cardiac events and mortality associated with electroconvulsive therapy: Correcting and updating a 2019 meta-analysis. Ethical Human Psychology and Psychiatry, repository.uel.ac.uk/item/8xyx0

Contact
Citizens Commission on Human Rights
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • The Hardest Part of Building an App Isn't Starting - It's Finishing
  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
  • Spring Into Your New Home at Heritage at South Brunswick
  • Justin Fairfax Dies in Apparent Murder Suicide
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
  • First Flight Society Selects John and Martha King as 2026 Paul E Garber First Flight Shrine Honorees
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • GitKraken Desktop 12.0 Introduces Agent Mode: Gives Developers Ultimate Control & Visualization While Scaling Parallel Agent Workflows
  • 5 Things to Check Before Calling for AC Repair in Philly
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • Now Presenting Flights of Fancy
  • Card makers turn to Pink and Main for tools to support their craft
_catLbl0 _catLbl1

Popular on ncarol.com

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 365
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 147
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
  • UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)

Similar on ncarol.com

  • Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • Seven Games That Make You Think (and Smile) Earn 2026 Mensa Select® Honors
  • New research identifies The Discovery Gap: Seven in 10 Americans say travel is no longer just about getting away
  • SilverBow Strategies Launches RFPArchon™, the First Product in Its Artemis AI Solutions™ Suite
  • The Hardest Part of Building an App Isn't Starting - It's Finishing
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute